PharmaceuticalsPhilippines: Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP)

Philippines: Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP)

 

Philippines has published Guidelines on Labeling Requirements of Drug Products under Maximum Retail Price (MRP).

The proposed Guidelines aim to provide streamlined and rational application  process  for  the  change  of  labeling  materials  under  MRP  including  drug molecules or drug formula that will be included in succeeding Executive Orders of MRP

The Guideliens apply to all licensed drug manufacturers, traders, and distributors of drugs products under MRP.

In accordance with the Guidance, the following MRP statement shall be printed on the primary and secondary packaging label of the drug product on a red strip (red background or red font):

UNDER DRUG PRICE REGULATION RETAIL PRICE NOT TO EXCEED [PRICE]

For primary label such as blister pack/foil strip, MRP statement shall be printed on every standard blister pack/foil strip. This shall exclude drug products in small containers.

The full text of the Guidelines is available HERE.

Leave a Reply

https://www.productcomplianceinstitute.com/wp-content/uploads/2025/03/logo-no-background-1.png
Atrium Centrum, Al. Jana Pawła II 27, 00-867 Warsaw
Kunstlaan / Avenue des Arts 56, Brussels
+48 575 570 017

Follow us:

The content provided on this website is not intended to and does not constitute legal advice. Submissions or postings to the website are not confidential. We do not warrant or guarantee the accuracy, completeness or adequacy of the content. Your use of the content on the website or materials linked from this website is at your own risk.

Copyright © Product Compliance Institute 2025

en_USEnglish